Annovis Bio saw promising results for Buntanetap in treating Alzheimer's and Parkinson's, but short cash runway prompts a ...

Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its ...

A recent study from the School of Medicine at Fujita Health University has brought new insights into the metabolic ...

Researchers at UAB found blows to the head, like football players regularly experience, play a “significant” role in a person ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its progressive nature and debilitating effects on motor function.

The NIH has found evidence of research misconduct against Eliezer Masliah, M.D., the longtime head of the National Institute ...

Tavapadon, a drug made by AbbVie to treat Parkinson’s disease, met phase 3 TEMPO-1 trial goals treated early Parkinson's disease and improved motor skills, the company reported on Thursday.

Parkinson's disease (PD), the second most common neurodegenerative disorder globally, has long baffled scientists with its progressive nature and ...

Users say the app makes them more mindful and less anxious. I Asked 3 Butchers How To Choose the Best Steak—They All Said the ...

How to Prepare for a Leadership Role When Your Boss Retires and Achieve Your Goals! (The Succession Solution!) ...

These results back up results from the TEMPO-3 trial, which tested tavapadon as an add-on therapy to levodopa and which also ...